TABLE 1

Patient Characteristics

						Standardized uptake value
						¹¹C-4DST	¹⁸F-FDG
Patient no.	Age (y)	Sex	Histology	TNM stage	Tumor diameter (mm)	Maximum	Mean	Maximum	Mean	Ki-67 index (%)	CD31-positive vessels (n)
1	56	M	Adenocarcinoma	pT2N0M0	31	4.7	2.2	10.9	3.7	81	816
2	79	F	Adenocarcinoma	pT1N0M0	14	1.8	1.1	1.3	0.7	16	381
			Adenocarcinoma		18	2.1	1.2	2.8	1.6	29	410
3	55	F	Adenocarcinoma	pT1N0M0	18	4.1	1.5	7.7	2.4	92	769
4	60	M	Adenocarcinoma	pT1N1M0	15	1.5	1.1	1.4	1.1	18	485
5	69	M	Adenocarcinoma	pT3N1M0	12	2.7	1.8	13.7	5.7	67	579
6	62	M	Adenocarcinoma	pT2N0M0	32	3.5	2.1	7.1	2.7	20	464
7	77	F	Adenocarcinoma	pT1N0M0	20	2.7	1.7	4.5	1.8	72	423
8	73	F	Adenocarcinoma	pT2N0M0	15	2.7	1.7	5.2	2.5	35	362
9	58	M	Squamous cell carcinoma	pT2N1M0	30	3.0	2.0	5.6	2.8	62	309
10	55	M	Large cell carcinoma	pT2N1M0	62	3.2	1.8	7.6	3.2	74	717
11	72	M	Adenocarcinoma	pT2N0M0	55	4.5	2.5	10.1	4.9	79	1,042
12	74	M	Squamous cell carcinoma	pT2N0M0	30	3.9	2.3	17.3	4.7	87	1,565
13	78	M	Adenocarcinoma	pT2N0M0	38	4.0	2.1	6.3	3.1	76	366
14	73	M	Adenocarcinoma^*	pT1N0M0	20	2.1	1.3	3.6	2.4	19	622
15	79	M	Adenocarcinoma	pT1N0M0	19	3.0	1.7	4.2	2.5	76	3,102
16	58	F	Adenocarcinoma	pT1N2M0	18	1.5	1.5	3.5	2.3	45	884
17	63	F	Adenocarcinoma	pT2N0M0	32	1.6	1.3	0.8	0.6	4	780
18	84	M	Adenocarcinoma^*	pT1N0M0	19	1.9	1.4	1.2	0.7	18	485

↵* Bronchioloalveolar carcinoma.